Glutaric aciduria type 1: Diagnosis, clinical features and long‐term outcome in a large cohort of 34 Irish patients
Open Access
- 14 June 2022
- journal article
- Published by Wiley in JIMD Reports
- Vol. 63 (4), 379-387
- https://doi.org/10.1002/jmd2.12302
Abstract
Glutaric aciduria type 1 (GA1) is a rare neurometabolic disorder that can lead to encephalopathic crises and severe dystonic movement disorders. Adherence to strict dietary restriction, in particular a diet low in lysine, carnitine supplementation and emergency treatment in pre-symptomatic patients diagnosed by high-risk screen (HRS) or newborn screen (NBS) leads to a favourable outcome. We present biochemical and clinical characteristics and long-term outcome data of 34 Irish patients with GA1 aged 1-40 years. Sixteen patients were diagnosed clinically, and 17 patients by HRS, prior to introduction of NBS for GA1 in the Republic of Ireland in 2018. One patient was diagnosed by NBS. Clinical diagnosis was at a median of 1 year (range 1 month to 8 years) and by HRS was at a median of 4 days (range 3 days to 11 years). 14/18 (77.8%) diagnosed by HRS or NBS had neither clinical manifestations nor radiological features of GA1, or had radiological features only, compared to 0/16 (0%) diagnosed clinically (p < 0.001). Patients diagnosed clinically who survived to school-age were more likely to have significant cerebral palsy and dystonia (7/11; 63.6% vs. 0/13; 0%, p < 0.001). They were less likely to be in mainstream school versus the HRS group (5/10; 50% vs. 12/13; 92.3%; p = 0.012). Clinical events occurring after 6 years of age were unusual, but included spastic diplegia, thalamic haemorrhage, Chiari malformation, pituitary hormone deficiency and epilepsy. The exact aetiology of these events is unclear.This publication has 30 references indexed in Scilit:
- Use of guidelines improves the neurological outcome in glutaric aciduria type IAnnals of Neurology, 2010
- Natural History, Outcome, and Treatment Efficacy in Children and Adults with Glutaryl-CoA Dehydrogenase DeficiencyPediatric Research, 2006
- Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiencyNeurology, 2005
- Glutaric aciduria type I: Outcome in the Republic of IrelandJournal of Inherited Metabolic Disease, 2004
- Correlation of genotype and phenotype in glutaryl‐CoA dehydrogenase deficiencyJournal of Inherited Metabolic Disease, 2004
- Neuroimaging findings in glutaric aciduria type 1Pediatric Radiology, 2003
- Type I glutaric aciduria, part 1: Natural history of 77 patientsSeminars in Medical Genetics, Part C of the American Journal of Medical Genetics, 2003
- Human Gene Mutation Database (HGMD®): 2003 updateHuman Mutation, 2003
- Prevention of cerebral palsy in glutaric aciduria type 1 by dietary managementArchives of Disease in Childhood, 2000
- Glutaric aciduria and suspected child abuseArchives of Disease in Childhood, 1999